HAP

Login to view your account.

Don't have an account? Click here.

Newsroom

News

RSS feed

Pennsylvanians That Didn’t Receive New Medicare Cards Urged to Follow-up

August 14, 2018

The Centers for Medicare & Medicaid Services (CMS), in conjunction with its distribution timeline, has completed mailing new Medicare cards to beneficiaries in Pennsylvania. Federal officials have provided instructions for residents who haven’t received their new card.

More >

AHA Calls for Changes to Stark Law to Ensure Greater Patient Care Coordination and Improved Outcomes

August 06, 2018

The American Hospital Association recently sent a letter to the Centers for Medicare & Medicaid Services calling for exceptions to the Stark Law to enable hospitals and physicians to coordinate care and improve patient outcomes.

More >

PA Hospital Perspective, Economic Impact Shared During Federal Opioid Policy Roundtable

August 03, 2018

Federal and state policymakers received input from business leaders, local officials and hospital and health care providers during a roundtable policy discussion this week in Somerset exploring the impact of the opioid crisis on economic development in Appalachia counties.

More >

PA Insurance Commissioner Issues Letter to HHS on State’s Plan to Implement Association Health Plans Rule

August 02, 2018

Today, Pennsylvania Insurance Commissioner Jessica Altman sent a letter to the U.S. departments of Labor and Health and Human Services outlining the state Insurance Department’s position on the implementation of a federal rule aiming to expand association health plans (AHP).

More >

Trump Administration Continues to Promote Less-Costly, Less-Generous Coverage

August 01, 2018

A newly finalized federal policy significantly extends the amount of time individuals may remain enrolled in short-term health insurance plans from three months to up to three years. The stated intent of the policy is to expand access to less expensive alternative insurance options; however, these plans are not subject to the full patient protections and benefits assured under the Affordable Care Act (ACA).

More >

Federal Blue Ribbon Panel on Biodefense Features Hospital Preparedness, Highlights PA’s Coordinated Preparedness

July 31, 2018

In testimony before today’s meeting of the Blue Ribbon Study Panel on Biodefense, U.S. Senator Bob Casey (D, PA) spoke about his efforts to reauthorize the hospital preparedness program and pointed to Pennsylvania as a leader in adopting a coordinated regional approach to preparedness.

More >

Surgeon General Announces Partnership with Hospitals to Combat Opioid Abuse

July 30, 2018

The U.S. Surgeon General Jerome Adams, M.D., announced that this fall his office will partner with the American Hospital Association to further combat the opioid epidemic.

More >

Providers Weigh In on MACRA during U.S. House E&C Hearing

July 26, 2018

Today, the U.S. House Energy and Commerce (E&C) Health Subcommittee held the fourth hearing on progress in the implementation of Medicare payment reforms under the Medicare Access and CHIP Reauthorization Act (MACRA) of 2015.

More >

U.S. House of Representatives Energy and Commerce Subcommittee on Health Hearing Provides an Update on 21st Century Cures Act Implementation

July 20, 2018

This week, the U.S. House of Representatives Energy and Commerce Subcommittee on Health held a hearing to provide a status update about the mental health provisions included in the 21st Century Cures Act. During the hearing, the Substance Abuse and Mental Health Services Administration (SAMHSA), the agency at the helm of implementing the Cures Act’s mental health provision, reported about the agency’s progress.

More >

Congressional Hearings Consider Avenues to Tackle Health Care Costs

July 18, 2018

Congressional committees on both sides of the Capitol in Washington, DC, are focusing on exploring the dynamics driving health care costs and possible policy avenues to consider. Transparency, drug prices, and paying for value are being featured prominently in policy discussions.

More >

Federal Policymakers Call for Reforms to Stark Law to Promote Care Coordination and Accelerate the Move to Value-Based Care

July 18, 2018

A hearing before the U.S. House Ways & Means Health Subcommittee—Modernizing Stark Law to Ensure the Successful Transition from Volume to Value in the Medicare Program—highlighted the regulatory burden of the Stark Laws and affirmed the commitment of federal policymakers to pursue reforms that will help promote integrated and coordinated care.

More >

Legal Challenge to 340B Payment Cut Rejected on Procedural Grounds; HAP Advocates for 340B Program As Crucial Tool in Helping Hospitals Managing Drug Costs

July 17, 2018

A federal appeals court upheld a lower court decision rejecting, on procedural grounds, a lawsuit brought by the American Hospital Association, the Association of American Medical Colleges, and America’s Essential Hospitals that could have prevented Medicare payment cuts from taking effect for many hospitals in the 340B Drug Pricing Program.

More >

Federal Task Force Created to Address Critical Drug Shortages

July 13, 2018

Addressing concerns about the continuing shortage of critical drugs, the Food and Drug Administration (FDA) yesterday released a statement from Commissioner Scott Gottlieb, MD, announcing the formation of a federal task. The task force will investigate the causes of the shortages and recommend solutions to ensure appropriate supplies of medications are always available.

More >

Reduced Resources for Insurance Navigators; Outreach Efforts will be Crucial to Encouraging Coverage

July 12, 2018

The Centers for Medicare & Medicaid Services (CMS) released its annual notice for federal grants to fund navigators that assist consumers in enrolling in the federal health insurance marketplace. For the second year, CMS reduced the funding available to support the outreach efforts.

More >

U.S. House Hearing Reviews Policy Impacting the 340B Drug Pricing Program

July 11, 2018

In a hearing before the U.S. House Energy and Commerce Health Subcommittee, federal lawmakers explored the purpose and administration of the 340B Drug Pricing Program; reviewed federal oversight and compliance; and garnered feedback on policy proposals.

More >

Page 1 of 33First   Previous   [1]  2  3  4  5  6  7  8  9  10  Next   Last   
« Close